Altered lipid parameters in HIV infection;Anomalies lipoproteiniques au cours de l'infection par le VIH

Annales de Medecine Interne

Volumn 147, Issue 5, 1996, Pages 333-343

  Keréveur, Anne ^a,b   Cambillau, Michele ^a   Kazatchkine, Michel ^a   Moatti, Nicole ^a  

^a HÔPITAL BROUSSAIS   (France)

^b HÔPITAL LARIBOISIÈRE   (France)

Author keywords

cholesterol; cytokines; HIV; triglycerides

Indexed keywords

ALPHA INTERFERON; INTERLEUKIN 1; INTERLEUKIN 6; TUMOR NECROSIS FACTOR; ZIDOVUDINE; CHOLESTEROL; LIPOPROTEIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; CACHEXIA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERTRIGLYCERIDEMIA; HYPOCHOLESTEROLEMIA; IN VITRO STUDY; IN VIVO STUDY; LIPID METABOLISM; REVIEW; BLOOD; PATHOPHYSIOLOGY; TIME;

CHOLESTEROL; HIV INFECTIONS; HUMANS; HYPERTRIGLYCERIDEMIA; LIPOPROTEINS; TIME FACTORS;

EID: 0030347177     PISSN: 0003410X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (111)

1. GALLIN JI, KAYE D, O'LEARY WM : Serum lipids in infection. N Engl J Med 1969 ; 281 : 1081-1086.
2. FISER RH, DEXNISTON JC, BEISEL WR : Infection with Diplococcus pneumoniae and Salmonella typhimurium in monkeys : chanses in plasma lipids and lipoproteins. J Infect Dis 1972 ; 725 : 54-60.
3. ROUZER CA, CERAMI A : Hypertriglyceridemia associated with Trypanosoma bruceii infection in rabbits : role of impaired trialyceride disposal mechanisms. Mol Biocliem Parasitai 1980 ; 2: 31-38.
4. LEES RS, FISER RH, BEISEL WR, BARTELLONI PJ : Effects of an experimental viral infection on plasma lipid and lipoprotein metabolism. Metabolism 1972 ; 21 : 825-833.
5. CENTERS FOR DISEASE CONTROL. Revision of the CDC surveillance case definition for acquired immunodeficiency syndrome. MMWR 1987 ; 36 (supl 15) : 3S-14S.
6. GRUNFELD C, KOTLER DP, HAMADEH R, TIERNEY A, WANG J, PIERSON RN Jr : Hypertriglyceridemia in the acquired immunodeficiency syndrome. Am J Mcd 1989 ; 86 : 2731.
7. GRUNFELD C, KOTLER DP, SHIGENAGA JK et al : Circulating Interferon a levels and hypertriglyceridemia in the acquired immunodeficiency syndrome. Am J Med 1991 ; 90 : 154-62.
8. SHOR-POSNER G, BASIT A, Lu et al : Hypocholesterolemia is associated with immune dysfunction in early human immunodeficiency virus-1 infection. Am J Med 1993 ; 94 : 515-9.
9. GRUNFELD C, PANG M, DOERRLER W, SHIGENAGA JK, JENSEN P, FEINGOLD KR : Lipids, lipoproteins, triglyceride clearance, and cytokines in human immunodeficiency virus infection and the acquired immunodeficiency syndrome. J Clin Endocriiwl Metal) 1992 ; 74 : 1045-52.
10. BLATT S, ZAJAC R, LUCEY D et al : Lipid abnormalities in HIV infection (abstract). VI International Conference on AIDS ; 1990 : Th. B207
11. COODLEY G, COODLEY MK : Hypocholesterolemia and malabsorption in HIV infection (letter). West J Med, 1991 ; 154 : 735.
12. FALKENBACH A, KLAUKE S, ALTIIOFF PH : Abnormalities in cholesterol metabolism cause peripheral neuropathy and dementia in AIDS : a hypothesis. Med Hypotheses 1990 ; 33:57-61.
13. GERVAIS A, AYRAULT-JARRIER M, REBOUL J etal: Apolipoprotein All in HIV-1 infection. Lancet 1992 ; 340 : 730731.
14. HELLERSTEIN MK, GRUNFELD C, Wu K, CHRISTIANSEN M, KAEMPFER S, KLETKE C, SHACKLETON CHL : Increased de novo hepatic lipogenesis in human immunodeficiency virus infection. J Clin Endocriiwl Metab 1993 ; 76 : 559-65
15. SAMMALKORPI K, VALTONEN V, KERTTULA Y, NIKKILa E, TASKINEN MR : Changes in serum lipoprotein pattern induced by acute infection. Metabolism 1988 ; 37: 859-65.
16. ANDERSON KM, CASTELLI WP, LEVY D : Cholesterol and mortality : 30 years follow-up from the Framinsham study. JAMA 1987 ; 257: 2176-2180.
17. WILLIAMS RR, SORLIE PD, MCNAMARA PM, KaNNEL WB, DAWBER TR : Cancer incidence by levels of cholesterol. JAMA 1981 ; 245 : 247-252.
18. SMITH GD, SHIPLEY MJ, MARMOT MG, ROSE G : Plasma cholesterol concentration and mortality. JAMA 1992 ; 267: 70-76.
19. GRUNFELD C, FEINGOLD KR : Tumor necrosis factor, cytokines and the hyperlipidemia of infection. Trends Endocriiwl Metab 1991 ;2:213-2I9.
20. HARRIS HW, GRUNFELD C, FEINGOLD KR, RAPP JH : Human very low density lipoproteins and chylomicrons can protect asainst endotoxin-induced death in mice. J Clin Invest 1990 ; 86 : 696-702.
21. MILDVAN D, MACHADO SG, WILETS I, GROSSBERG SE : Endogenous Interferon and triglyceride concentrations to asses response to zidovudine in AIDS and advanced AIDS-related complex. Lancet 1992 ; 339 : 453-456.
22. EMILIE D, PEUCHMAUR M, MAILLOT MC et al : Production of interleukins in human immunodeficiency virus-1-replicating lymph nodes. J Clin Invest 1990 ; 86 : 148-59.
23. OSBORN L, KUNKEL S, NABEL GJ : Tumor necrosis factor a and interleukin 1 stimulate the human immunodeficiency virus enhancer by activation of the nuclear factor kB. Pmc NatlAcad Sei USA 1989 ; 86 : 2336-40.
24. BEUTLER B, MAHONEY J, LETRANG N, PEKALA P, CERAMI A : Purification of cachectin, a lipoprotein lipase suppressing hormone secreted by endotoxin-induced RAW 264.7 cells. J Exp Med 1985 ; 767 : 984-95.
25. PATTON JS, SHEPARD HM, WILKING H et al : Interferons and tumor necrosis factors have similar catabolic effects on 3T3-L1 cells. Pmc Natl Acad Sei USA 1986 ; 83 : 8313-17.
26. GREENBERG AS, NORDAN RP, McI.vrosH J, CALVO JC, Scow RO, JABLONS D : Interleukin 6 reduces lipoprotein lipase activity in adipose tissue of mice in vivo and in 3T3Ll adipocytes : a possible role for interleukin 6 in cancer cachexia. Cancer Res 1992 ; 52 : 4113-6.
27. KAWAKAMI M, MURASE T, OGAWA H et al : Human recombinant TNF suppresses lipoprotein lipase activity and stimulates lipolysis in 3T3-L1 cells. J Biochem 1987 ; 101 : 331-8.
28. KERN PA : Recombinant human tumor necrosis factor does not inhibit lipoprotein lipase in primary cultures of isolated human adipocytes. J Lip Res 1988 ; 29 : 909-14.
29. GRUNFELD C, FEINGOLD KR : The metabolic effects of tumor necrosis factor and other cytokines. Biotherapy 1991 ;3: 143-58.
30. KRAUSS RM, GRUNFELD C, DOERRLER WT, FEINGOLD KR : Tumor necrosis factor acutely increases plasma levels of very low density lipoproteins of normal size and composition. Endocrinology 1990 ; 727; 1016-21.
31. FEINGOLD KR, GRUNFELD C : Tumor necrosis factor alpha stimulates hepatic lipoeenesis in the rat in vivo. J Clin Invest \9 80 : 184-190.
32. GRUNFELD C, VERDIER JA, NEESE RA, MOSER AH, FEINGOLD KR : Mechanisms by which tumor necrosis factor stimulates hepatic fatty acid synthesis in vivo. J Lip Res 1988 ; 29 : 1327-35.
33. GRUNFELD C, GULLI R, MOSER AH, GAVIN LA, FEINGOLD KR : Effect of tumor necrosis factor administration in vivo on lipoprotein lipase activity in various tissues of the rat. J Lip Res 1989 ; 30 : 579-585.
34. CHAJEK-SHAUL T, FRIEDMAN G, STEIN O, SHILONI E, ETIENNE J, STEIN Y : Mechanisms of the hypertriglyceridemia induced by tumor necrosis factor administration to rats. Biocliim Biopliys Ada 1989 ; 7007 : 316-24.
35. BLACKHAM M, CESAR D, PARK OJ et al : Effects of recombinant monokines on hepatic pyruvate dehydrogenase, pyruvate dehydrogenase kinase, de novo lipogenesis and plasma trielycerides. Abolition by prior fastinc. Biochem J, 1992; 284: 129-135.
36. FEINGOLD KR, ADI S, STAPRANS I et al : Diet affects the mechanisms by which TNF stimulates hepatic trielyceride production. Am J Physiol 1990 ; 259 : E177-1847
37. FEINGOLD KR, SERIO MK, ADI S, MOSER AH, GRuNFELD C : Tumor necrosis factor stimulates hepatic lipid synthesis and secretion. Endocrinology, 1989 ; 124 : 2336-42.
38. FEINGOLD KR, SOUED M, STAPRANS I et al : The effect of TNF on lipid metabolism in the diabetic rat : evidence that inhibition of adipose tissue lipoprotein lipase activity is not required for TNF induced hyperlipidemia. J Clin Invest 1989; S3: 1116-21.
39. GRUMFELD C, FEINGOLD KR : Metabolic disturbances and wastins in the acquired immunodeficiency syndrome. Eng J lied 1992 ; 327 : 329-337.
40. CONSTANS J, PELLEGRIN JL, PEUCHANT E et al : Plasma lipids in HIV-infected patients : a prospective study in 95 patients. EurJ Clin Invest 1994 ; 24 : 416-20.
41. AUSKRUT P, LlABAKK NB, MuLLER F, LlEN E, ESPEVIK T,
42. FROLAND SS : Serum levels of tumor necrosis factor-a (TNFa) and soluble TNF receptors in human immunodeficiency virus type 1 infection-Correlations to clinical, immunoloaical, and virologie parameters. J Infect Dis 1994 ; 769: 420-4.
43. POLI G, ORENSTEIN JM, KINTER A, FOLKS TM, FAUCI AS : Interferon alpha but not AZT suppresses HIV expression in chronically infected cell lines. Science 1989 ; 244 : 575-8.
44. KROWN SE, GOLD JWM, NIEDZWIECKI D et al : Interferon a with zidovudine : safety, tolerance, clinical and virologie effects in patients with Kaposi sarcoma associated with the acquired immunodeficiency syndrome (AIDS). Ann Intern Meil 1990; 772 : 805-11.
45. LANE HC, DAVEY V, KOVACS JA et al : Interferon a in patients with asymptomatic human immunodeficiency virus (HIV) infection. Ann Intern Med 1990 ; 112 : 812-8.
46. KOBAYASHI N, HAMAMOTO Y, KOYANAGI Y, CHEN IS, YAMAMOTO N : Effect of interleukin-1 on the augmentation of human immunodeficiency virus gene expression. Biochem Biophys Res Commun 1989 ; 765 : 715.
47. FEINGOLD KR, SOUED M, SERIO MK, MOSER AH, DINARELLO CA, GRUNFELD C : Multiple cytokines stimulate hepatic lipid synthesis in vivo. Eiulocrinologv 1989 ; 725 : 267-74.
48. GRUNFELD C, SOUED M, ADI S, MOSER AH, DINARELLO CA, FEINGOLD KR : Evidences for two class of cytokines that stimulate hepatic lipogenesis : relationships among tumor necrosis factor, interleukin-1 and interferon alpha. Endocrinology, 1990 ; 127:46-54.
49. EHXHOLM C, AHO K, HUTTUNEN JK et al : Effect of interferon on plasma lipoproteins and on the activity of postheparin plasma upases. Arteriosclerosis, 1982 ; 2 : 68-73.
50. MASSARO ER, BORDEN EC, HAWKINS MJ, WIEBE DA, SHRAGO E : Effects of recombinant interferon-alpha-2 treatment upon lipid concentrations and lipoprotein composition. J Interferon Res 1986 ; 6 : 655-62.
51. DESTEFANO E, FRIEDMAN RM, FRIEDMAN-KLEIN AE et al : Acid-labile human leukocyte interferon in homosexual men with Kaposi's sarcoma and lymphadenopathy. J Infect Dis 1982; 146 :451-5.
52. EYSTER ME, Goeddert JJ, POON MC, PREBLE OT : Acid-labile alpha interferon : a possible preclinical marker for the acquired immunodeficiency syndrome in haemophilia. W Engl J Med 1983; 309 : 583-6.
53. BUIMOVICI-KLEIN E, LANGE M, KLEIN RJ, GRIECO MH, COOPER LZ : Long-term follow-up of serum-interferon and its acid-stability in a croup of homosexual men. AIDS Res 1986 ;2 : 99-108.
54. MOLINA JM, SCADDEN DT, BYRN R, DlNARELLO CA, GROOPMAN JE : Production of tumor necrosis factor a and interleukin Ib by monocytic cells infected with human immunodeficiency virus. J Clin Inves, 1989 ; 84 : 733-7.
55. WEISS L, HAEFFNER-CAVAILLON N, LAUDE M, KaZATCHKINE MD : HIV infection is associated with the spontaneous production of interleukin-1 (IL-1) in vivo and with an abnormal release of IL-1 a in vitro. AIDS, 1989 ; 3 : 695-9.
56. PRICE SR, MIZEL SB, PEKALA PH : Regulation of lipoprotein lipase synthesis and 3T3-L1 adipocyte metabolism by recombinant interleukin-1. Biochem Biophys Ada 1986 ; 889: 374-81.
57. FEINGOLD KR, SOUED M, ADI S et al : Effect of interleukin-1 on lipid metabolism in the rat : similarities to and differences from tumor necrosis factor. Arterioscler Tlimmbl99\ ; 11 : 495-500.
58. POLI G, BRESSLER P, KINTER A et al: Interleukin 6 induces human immunodeficiency virus expression in infected monocytic cells alone and in synergy with tumor necrosis factor a by transcriptional and post-transcriptional mechanisms. J Exp Afed 1990 ; 772 : 151-8.
59. TESMER VM, RAJADHYAKSHA A, BABIN J, BINA M : NF-IL6 mediated transcriptional activation of the long terminal repeat of the human immunodeficiency virus type 1. Proc NatlAcadSci USA 1993 ; 90 : 7298-302.
60. GRUNFELD C, ADI S, SOUED M, MOSER AH, FIERS W, FEINGOLD KR : Search for mediators of the lipogenic effects of tumor necrosis factor : potential role for interIeukin-6. Cancer Res 1990 ; 50: 4233-8.
61. BREEN EC, REZAI AR, NAKAJIMA K et al : Infection with HIV is associated with elevated IL-6 levels and production. J Immunol 1990 ; 144 : 480-4.
62. BIRX DL, REDFIELD RR, TENCER K et al : Induction of interIeukin-6 durinc human immunodeficiency virus infection. Blood 1990^ 76: 2303-10.
63. DIXON RM, BORDEN EC, KEIM N et al: Decreases in serum high density lipoprotein cholesterol and total cholesterol resulting from naturally produced and recombinant DNA derived leukocyte interferons. Metabolism 1984 ; 33 : 400-4
64. MASSARO ER, BORDEN EC, HAWKINS MJ, WIEDE DA, SHRAGO E : Effects of recombinant interferon a2 treatment upon lipid concentrations and lipoprotein composition. J Interferon Res, 1986 ; 6 : 655-62.
65. FISCHER DG, TAL N, NOVICK D, BARAK S, RUBINSTEIN M : An antiviral soluble form of the LDL receptor induced by interferon. Science 1993 ; 262 : 250-3.
66. FUNK JL, FEINGOLD KR, MOSER AH, GRUNFELD C : Lipopolysaccharide stimulation of RAW 264.7 macrophages induces lipid accumulation and foam cell formation. Atherosclerosis 1993 ; 98: 67-82.
67. KOTLER DP, WANG J, PIERSON RN : Body composition studies in patients with the acquired immunodeficiency syndrome. Am J Clin Niitr 1985, 42 : 1255-65.
68. KOTLER DP, TIERNEY AR, CULPEPPER-MORGAN JA, WANG J, PIERSON RN Jr : Effect of home total parenteral nutrition upon body composition in patients with acquired immunodeficiency syndrome. J Parenter Enterai Nutr 1992 ; 14 : 454-8.
69. MELCHIOR JF, SALMON D, RIGAUD P et al : Increased energy expenditure and lean body mass in HIV infected patients (abstract). VII International Conference on AIDS, Florence, June 16-21, 1991, Th. B204.
70. HOMMES MJT, ROMIJN JA, GODFRIED MH et al : Increased resting energy expenditure in human immunodeficiency virus-infected men. Metabolism 1990 ; 39 : 1186-90.
71. GRUNFELD C,' PANG M, SHIMIZU L, SHIGENAGA JK, JENSEN P, FEINGOLD KR : Resting energy expenditure, caloric intake, and short-term weight change in human immunodeficiency virus infection and the acquired immunodeficiency syndrome. Am J Clin Nutr 1992 ; 55 : 455-60.
72. BRENNAN MF : Uncomplicated starvation versus cancer cachexia. Cancer Res, 1977 ; 37: 2359-64.
73. KOTLER DP, TIERNEY AR, WANG J, PIERSON RN Jr : Magnitude of body-cell-mass depletion and the timing of death from wasting in AIDS. Am J Clin Nutr, 1989 ; 50 : 444-7.
74. DUERDEN JM, GIBBONS GF : Secretion and storage of newly synthesized hepatic triacylglycerol fatty acids in vivo in different nutritional states and diabetes. J Lip Res 1988; 27: 1174-81.
75. AZAIN MJ, FUKUDA N, CHAO FF, YAMAMOTO M, O.NTKO JA : Contributions of fatty acid and sterol synthesis to triglyceride and cholesterol secretion by the perfused rat liver in genetic hyperlipemia and obesity. J Biol Cliein 1985; 260: 174-81.
76. TIIEOLOGIDES A : Pathogenesis of cachexia in cancer.A rewiew and a hypothesis. Cancer, 1972 ; 29 : 484-8.
77. HYLTANDER A, DROTT C, KORNER V : Elevated energy expenditure in cancer patients with solid tumors. Enr J Cancer ]99\ ; 27.-9-15.
78. FREDRIX EWHM, SOETERS PB, WOUTERS EFM, DEERENBERG IM, VON MEYENFELDT MF, SARIS WHM : Effect of different tumor types on resting energy expenditure. Cancer Res 1991 ;J/: 6138-41.
79. MULLIGAN HD, TISDALE MJ : Lipogenesis in tumor and host tissues in mice bearinc colonie adenocarcinomas. Br J Cancer 1991 ; 63 : 719-22.
80. UTSUMI K, TAKAI Y, TADA T, OIIZEKI S, FUJIWARA H, HAMAOKA T : Enhanced production ofIL-6 in tumor-bearing mice and determination of cells reponsible for its augmented production. J 1 minimal 1990 ; 145 : 397-403.
81. FEARON KCH, MCMILLAN DC, PRESTON T, WINSTANLEY FP, CRUICKSHANK AM, SHENKIN A : Elevated circulating interleukin 6 is associated with an acute-phase response but reduced fixed hepatic protein synthesis in patients with cancer. Ann Surg 1991 ; 213 : 26-31.
82. BLACK K, GARRETT IR, MUNDY GR : Chinese hamster ovary cells transfected with the murine IL-6 gene cause hypercalcemia as well as cachexia, leukocytosis and thrombocytosis in tumor bearina nude mice. Endocrinology 1991 ; 128 : 2657-9.
83. STRASSMANN G, FONG M, KENNEY JS, JACOB CO : Evidence for the involvement of interleukin 6 in experimental cancer cachexia. J Clin Invest 1992 ; 89 : 1681-4.
84. BEUTLER B, CERAMI A : Cachectin and tumor necrosis factor as two sides of the same biological coin. Nature 1986 ; 320: 584-8.
85. BEUTLER B, CERAMI A : Cachectin : more than a tumor necrosis factor. NEngI J Med, 1987 ; 316 : 379-85.
86. LLOVERA M, LOPEZ-SORIANO FJ, ARGILES JM : Effects of tumor necrosis factor on muscle protein turnover in female Wistar rats. J NatI Cancer Inst 1993 ; 85 : 1334-9.
87. GOODMAN MN : Tumor necrosis factor induces skeletal muscle protein breakdown in rats. Am J Physiol 1991 ; 260 : E727-30.
88. SOCIIER SH, FRIEDMAN A, MARTINEZ D : Recombinant human tumor necrosis factor induces acute reductions in food intake and body weicht in mice. J Exp Med 1988 ; 167: 1957-62.
89. GRUNFELD C, WILKING H, NEESE Retal: Persistence of the hypertriglyceridemic effect of tumor necrosis factor despite development of tachyphylaxis to its anorectic/cachectic effects in rats. Cancer Res 1989 ; 49 : 2554-60.
90. STOVROFF MC, FRAKER DL, SWEDENBORG JA, NORTON JA : Cachectin/tumor necrosis factor : a possible mediator of cancer anorexia in the rat. Cancer Res 1988 ; 48:4567-72.
91. OLIFF A, DEFEO-JONES D, BOYER M et al : Tumors secretin human TNF/cachectin induce cachexia in mice. Cell 1987; 50 : 555-63.
92. B ALKWILL F, BURKE F, TALBOT D, TAVERNIER J, OSBORNE R, NAYLOR S, DURBIN H, FIERS W : Evidence for tumor necrosis factor production in cancer. Lancet 1987 ; 2 : 1229-32.
93. BUDKA H, MAIER H, POHL P : Human immunodeficiency virus in vacuolar myelopathy of the acquired immunodeficiency syndrome. N Engl J Med 1988 ; 319 : 1667-8.
94. KOENIG S, GENDELMAN HE, ORENSTEIN JM et al : Detection of AIDS virus in macrophages in brain tissue from AIDS patients with encephalopathy. Science 1985 ; 233 : 1089-93.
95. BONI J, EMMERICH BS, LEIB SL, WIESTLER OD, SCHUPBACH J, KLEIHUES P : PCR identification of HIV-1 DNA sequences in brain tissues of patients with AIDS encephalopathy. Neurology 1993 ; 43 : 1813-7.
96. PETITO CK, NAVIA BA, Cno ES, JORDAN BD, GEORGE DC, PRICE RW : Vacuolar myelopathy pathologically resembling subacute combined degeneration in patients with the acquired immunodeficiency syndrome. N Engl J Med 1985 \312: 874-9.
97. PRICE RW, BREW B, SIDTIS J, ROSENBLUM M, SCHECK AC, CLEARY P : The brain in AIDS : central nervous system HIV-1 infection and AIDS dementia complex. Science 1988 ; 239 : 586-92.
98. NAVIA BA, CHO ES, PETITO CK, PRICE R : The AIDS dementia complex : II. Neuropatholosy. Ann Neural 1986 ; 19: 525-35.
99. PATTERSON BK, EHRENPREIS ED, YOKOO H : Focal enterocyte vacuolization. A new microscopic finding in the acquired immune deficiency wastins syndrome. Am J Clin Patlwl\993;99:24-7.
100. TYOR WR, GLASS JD, BAUMRIND N, MCARTHUR JC, GRIFFIN JW, BECKER PS, GRIFFIN DE : Cytokine expression of macrophaces in HIV-1 associated vacuolar myelopathy. Neurology, 1993 ; 43 : 1002-9.
101. JANNSEN RS, CORNBLATH DR, EPSTEIN LG, MCARTHUR J, PRICE RW : Human immunodeficiency virus (HIV) infection and the nervous system : report from The American Academy of Neurolosy AIDS Task Force. Neurology 1989; 39: 119-22.
102. VoxRoENN JH, ROTH EL, CRAIG R : HIV-related cache-xia : potential mechanisms and treatment. Oncology, 1992;49(suppl 2):50-4.
103. HELLERSTEIN MK, KAHN J, MUDIE H, VITERI F : Current approach to the treatment of human immunodeficiency virus-associated weight loss : pathophysiologic considerations and emergin manacement strateaies. Semin Oncol 1990 ; 17 (suppl 9) : 17-33.
104. TCHEKMEDYIAN NS, TAIT N, MOODY M, AISNER J : Highdose megestrol acetate : a possible treatment for cachexia. JAMA 1987; 9: 1195-8.
105. Vo.NRoENN JH, MURPHY RL, WEBER KM, WILLIAMS LM, WEITZMAN SA : Megestrol acetate for treatment of cachexia associated with human immunodeficiency virus (HIV) infection. Ann Intern Med 1988 ; 709 : 840-41.
106. SCHMOLL E, WILKC H, THOLE R, PREUSSER P, WILDFANG I, SCHMOLL HJ : Meaestrol acetate in cancer cachexia. Seinin Oncol\99\ ; 18: 32-4.
107. MULLIGAN K, GRUNFELD C, HELLERSTEIN MK, NEESE RA, SCHAMBELAN M : Anabolic effects of recombinant human growth hormone in patients with wasting associated with human immunodeficiency virus infection. J Clin Endocrinol Metab 1993 ; 77: 956-62.
108. KRENTZ AJ, KOSTER FT, CRIST DM, FINN K, JOHNSON LZ, BOYLE PJ, SHADE DS : Anthropometrie, metabolic and immunological effects of recombinant human growth hormone in AIDS and AIDS-related complex. J AIDS, 1993 ; 6:245-51.
109. RUDMAN D, FELLEr AG, NAGRAJ HS et al : Effects of human growth hormone in men over 60 years old. N Engl J Med 1990 ; 323 : 1-6.
110. SCHAMBERLAN M, MULLIGAN K, GRUNFELD C, DAAR E, LAMARCA A, BREITMEYER J : Recombinant human growth hormone (rhGHJ increases lean body mass (LBM) and improves functional performance in patients with HIV-associated wasting. Second national conference, hitman retrovirus and related infections, Washington DC, 1995, LB15.
111. KOTLER DP, TIERNEY AR, ALTILIO D, WANG J, PIERSON RN : Body mass repletion during ganciclovir therapy of cytomegalovirus infections in patients with the acquired immunodeficiency syndrome. Arch Intern Med 1989 ; 749 :901-5.